Dorman Products (NASDAQ: DORM) reported Q2 EPS of $0.47, $0.04 better than the analyst estimate of $0.43. Revenue for the quarter came in at $233.2 million versus the consensus estimate of $202.7 million.

2020 Guidance
Due to the ongoing uncertainty of the economic environment, it remains difficult to determine the full impact that the pandemic will have on overall demand and Dorman’s operations. Therefore, Dorman is not providing guidance for the remainder of fiscal 2020 at this time.

For earnings history and earnings-related data on Dorman Products (DORM) click here.